Bristol

Thursday, 23 July 2015

Wall Street JournalBristol-Myers Revenue Boosted by Cancer Drug OpdivoWall Street JournalFor years, researchers struggled to figure out how to enlist the body's own immune defenses in the fight against cancer, and many companies shied away from the field due to the risks. Now, immunotherapy sales are helping propel sales growth at Bristol, ...and more »